What does Pharmacie des Hamendes do?

Pharmacie des Hamendes is a pharmacy in Pont-à-Celles. Private Limited, started on 30 September 2020, 1 establishment.

What is the address of Pharmacie des Hamendes?

The registered office of Pharmacie des Hamendes is located at Chaussée de Nivelles(LUT) 285, 6238 Pont-à-Celles.

Is Pharmacie des Hamendes still active?

Yes. According to the CBE (17 September 2026) Pharmacie des Hamendes is active, legal situation “Normale toestand”, started on 30 September 2020.

Is Pharmacie des Hamendes registered on Peppol?

Yes, Pharmacie des Hamendes is registered on the Peppol network with ID 0208:0755473117.

What is the enterprise number of Pharmacie des Hamendes?

The enterprise number of Pharmacie des Hamendes is BE0755473117.

When was Pharmacie des Hamendes founded?

Pharmacie des Hamendes was founded on 30 September 2020.

Who are the directors of Pharmacie des Hamendes?

According to the 2025 annual accounts, the directors of Pharmacie des Hamendes are: ANTHONY SACCOCCIO, CASSANDRA BROWET.

Is Pharmacie des Hamendes a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 September 2020; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Pharmacie des Hamendes make in 2025?

Pharmacie des Hamendes posted a profit after taxes of € 119,816 in financial year 2025.

What is the revenue of Pharmacie des Hamendes?

As a small company, Pharmacie des Hamendes is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 213,984.

How many employees does Pharmacie des Hamendes have?

According to the 2025 annual accounts, Pharmacie des Hamendes has 0 full-time equivalents (FTE).

Pharmacie des Hamendes (Private Limited) - Pont-à-Celles

Dossier Pharmacie des Hamendes, printed on 17 September 2026 from databakkes.be/en/0755473117/pharmacie-des-hamendes. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie des Hamendes from Pont-à-Celles, company number BE0755473117, closed financial year 2025 with a result of € 119,816 after tax. For that financial year Pharmacie des Hamendes recorded a gross margin of € 213,984 and equity of € 249,713. Compared with financial year 2024, the result moved from € 103,093 to € 119,816. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 249,713

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 119,816

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 104,272

▼ 58% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 19,779

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 143,001

▼ 18% vs 2024

€ 33,119 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 91,575

▲ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,200

▲ € 3,679 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 226,802 Gross margin 2022: € 226,802 First fiscal year in the series	€ 179,849 Gross margin 2023: € 179,849 ▼ 21% vs 2022 (€ 226,802) Unfavourable step	€ 203,540 Gross margin 2024: € 203,540 ▲ 13% vs 2023 (€ 179,849) Favourable step	€ 213,984 Gross margin 2025: € 213,984 ▲ 5% vs 2024 (€ 203,540) Favourable step	▲ 5%
Profit after taxes	€ 116,509 Profit after taxes 2022: € 116,509 First fiscal year in the series	€ 65,875 Profit after taxes 2023: € 65,875 ▼ 43% vs 2022 (€ 116,509) Unfavourable step	€ 103,093 Profit after taxes 2024: € 103,093 ▲ 56% vs 2023 (€ 65,875) Favourable step	€ 119,816 Profit after taxes 2025: € 119,816 ▲ 16% vs 2024 (€ 103,093) Favourable step	▲ 16%
Equity	€ 275,930 Equity 2022: € 275,930 First fiscal year in the series	€ 266,805 Equity 2023: € 266,805 ▼ 3% vs 2022 (€ 275,930) Unfavourable step	€ 249,897 Equity 2024: € 249,897 ▼ 6% vs 2023 (€ 266,805) Unfavourable step	€ 249,713 Equity 2025: € 249,713 Unchanged (€ 249,897) Unfavourable step
Total debts	€ 444,705 Total debts 2022: € 444,705 First fiscal year in the series	€ 360,818 Total debts 2023: € 360,818 ▼ 19% vs 2022 (€ 444,705) Favourable step	€ 407,096 Total debts 2024: € 407,096 ▲ 13% vs 2023 (€ 360,818) Unfavourable step	€ 249,933 Total debts 2025: € 249,933 ▼ 39% vs 2024 (€ 407,096) Favourable step	▼ 39%
Cash	€ 242,330 Cash 2022: € 242,330 First fiscal year in the series	€ 182,272 Cash 2023: € 182,272 ▼ 25% vs 2022 (€ 242,330) Unfavourable step	€ 250,392 Cash 2024: € 250,392 ▲ 37% vs 2023 (€ 182,272) Favourable step	€ 104,272 Cash 2025: € 104,272 ▼ 58% vs 2024 (€ 250,392) Unfavourable step	▼ 58%
Land & buildings	-	-	-	€ 8,846 Land & buildings 2025: € 8,846 First fiscal year in the series
Retained profit	€ 215,930 Retained profit 2022: € 215,930 First fiscal year in the series	€ 206,805 Retained profit 2023: € 206,805 ▼ 4% vs 2022 (€ 215,930) Unfavourable step	€ 189,897 Retained profit 2024: € 189,897 ▼ 8% vs 2023 (€ 206,805) Unfavourable step	€ 189,713 Retained profit 2025: € 189,713 Unchanged (€ 189,897) Unfavourable step
Dividend	€ 8,315 Dividend 2022: € 8,315 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 ▲ € 66,685 vs 2022 (€ 8,315) Unchanged	€ 120,000 Dividend 2024: € 120,000 ▲ 60% vs 2023 (€ 75,000) Unchanged	€ 120,000 Dividend 2025: € 120,000 Unchanged (€ 120,000) Unchanged
Bank debt	€ 265,296 Bank debt 2022: € 265,296 First fiscal year in the series	€ 218,379 Bank debt 2023: € 218,379 ▼ 18% vs 2022 (€ 265,296) Favourable step	€ 175,298 Bank debt 2024: € 175,298 ▼ 20% vs 2023 (€ 218,379) Favourable step	€ 143,001 Bank debt 2025: € 143,001 ▼ 18% vs 2024 (€ 175,298) Favourable step	▼ 18%
Balance sheet total	€ 720,635 Balance sheet total 2022: € 720,635 First fiscal year in the series	€ 627,622 Balance sheet total 2023: € 627,622 ▼ 13% vs 2022 (€ 720,635) Unchanged	€ 656,993 Balance sheet total 2024: € 656,993 ▲ 5% vs 2023 (€ 627,622) Unchanged	€ 499,646 Balance sheet total 2025: € 499,646 ▼ 24% vs 2024 (€ 656,993) Unchanged	▼ 24%
Employees (FTE)	0.8 Employees (FTE) 2022: 0.8 First fiscal year in the series	-	0.5 Employees (FTE) 2024: 0.5 First fiscal year in the series	0 Employees (FTE) 2025: 0 ▼ 0.5 vs 2024 (0.5) Unchanged	▼ 0.5

Key figures of Pharmacie des Hamendes, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie des Hamendes?

What happened at Pharmacie des Hamendes in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 119,816 (▲ 16% vs 2024). Source: NBB ↗
Oct 1, 2020 New establishment in Charleroi. KBO
Sep 30, 2020 Start of the company according to the CBE. KBO

In short

From € 116,509 profit in 2022 to € 119,816 profit in 2025.

Paid € 112,245 in corporate taxes since 2022.

Best year ever: 2025, with € 119,816 profit.

Paid out € 323,315 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Pharmacie des Hamendes? We notify you, reason included.

Follow Pharmacie des Hamendes

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ANTHONY SACCOCCIO CASSANDRA BROWET

Pharmacie des Hamendes

Behind Pharmacie des Hamendes are ANTHONY SACCOCCIO and CASSANDRA BROWET.

See the full network in the app

Directors

According to the 2025 annual accounts

ANTHONY SACCOCCIO

Director

CASSANDRA BROWET

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Nivelles(LUT) 285

6238 Pont-à-Celles

2.308.239.417

Chaussée du Château Mondron 69

6040 Charleroi

Active since 1 October 2020

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0755.473.117
VAT number: BE 0755.473.117
Registered office: Chaussée de Nivelles(LUT) 285, 6238 Pont-à-Celles
Names & denominations: Pharmacie des Hamendes
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 September 2020
Peppol: Active · Active since 12 Dec 2025
Contact: [email protected]
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗